Together, these results indicated that IFNγ is essential for the pruning of CD45−CD31high tumor endothelial cells and the accumulation of CD8+ T cells into tumors during anti-CTLA-4 therapy but not for the formation of TA-HEVs or the modulation of their phenotype. Here, IFNG is linked to neoplasm.